Skip to main content

Nonprofit · EIN 52-1224577

BIOTECHNOLOGY INNOVATION ORGANIZATION

Tax-exempt · WASHINGTON, DC 20005

Financials

$113.8M$91.6M2023$117.7M$100M2024
Revenue Expenses · by fiscal year end
Financials of BIOTECHNOLOGY INNOVATION ORGANIZATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$117,748,708$100,010,786$17,737,922$170,089,094$76,918,293$93,170,801
December 31, 2023990$113,768,509$91,630,164$22,138,345$156,639,347$79,279,320$77,360,027
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$0
Program service revenue
$91,769,762
Investment income
$9,375,263
Royalties
$16,603,683
Net gain from sales of assets
$4,824,597
Other revenue
$16,603,683

Expenses

Grants and similar amounts paid
$2,331,287
Compensation of officers, directors and key employees
$5,683,009
Other salaries and wages
$29,026,368
Salaries, compensation and benefits (total)
$41,996,482
Professional fundraising fees
$0
Legal fees
$1,171,505
Accounting fees
$98,136
Occupancy
$4,133,690
Travel
$1,733,037
Depreciation
$914,712

Balance sheet and other

Total assets, start of year
$156,639,347
Total assets, end of year
$170,089,094
Total liabilities, end of year
$76,918,293
Net assets, end of year
$93,170,801
Land, buildings and equipment
$15,928,289
Publicly traded securities
$85,815,523
Net assets without donor restrictions
$93,170,801
Gross unrelated business income
$40,500
Gross receipts
$214,116,938
Employees
180
Volunteers
113
Year formed
1981
State of legal domicile
DC

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
JOHN F CROWLEYPRESIDENT AND CEO
Trustee or director, Officer
40$2,747,033$365,352
RACHEL K KINGINTERIM PRESIDENT AND CEO
Officer
40$1,658,415$17,084
ELIZABETH CARTIER ESHAMCHIEF SCIENCE OFFICER
Highest-paid employee
40$1,012,398$18,928
STEPHEN JASKOCHIEF BUSINESS AND FINANCIAL OFFICER
Officer
40$808,510$86,616
PETER MCHUGHCHIEF LEGAL OFFICER
Highest-paid employee
40$688,807$90,259
RICHARD MASTERSCHIEF PUBLIC AFFAIRS & MARKETING OFF
Highest-paid employee
40$744,710$26,368
LETONIA D FYKESCHIEF EVENTS & INDUSTRY PROGRAMS OFFICER
Highest-paid employee
40$596,087$72,996
JOHN MURPHYCHIEF POLICY OFFICER
Highest-paid employee
40$567,043$27,095
MICHELLE MCMURRY-HEATHFORMER PRESIDENT AND CEO
Former
40$264,130$0
FRITZ BITTENBENDERBOARD & HEALTH SECTION VICE CHAIR
Trustee or director, Officer
2$0$0
GRACE E COLONEMERGING COMPANIES SECTION V CHAIR
Trustee or director, Officer
2$0$0
PAUL J HASTINGSIMMEDIATE PAST CHAIR
Trustee or director, Officer
2$0$0
ELIZABETH LEWIS UNTIL 32024ASSOCIATE VICE CHAIR & SECRETARY
Trustee or director, Officer
2$0$0
TED W LOVEBOARD & HEALTH SECTION CHAIR
Trustee or director, Officer
2$0$0
WILLIAM J NEWELLASSOCIATE VICE CHAIR & SECRETARY
Trustee or director, Officer
2$0$0
103 more people on this return
NameTitleHours / weekCompensation
ANNA RATH UNTIL 32024AGRICULTURE & ENV SECTION CHAIR
Trustee or director, Officer
2$0
DUANE J SIMPSONAGRICULTURE & ENV SECTION VICE CHAIR
Trustee or director, Officer
2$0
ERIKA SMITHEMERGING COMPANIES SECTION CHAIR
Trustee or director, Officer
2$0
TAD SONSTEGARDAGRICULTURE & ENV SECTION VICE CHAIR
Trustee or director, Officer
2$0
BRADFORD A ZAKESTREASURER
Trustee or director, Officer
2$0
ANGELA CARISA AILLONIDIRECTOR (UNTIL DECEMBER 2024)
Trustee or director
2$0
STEVE ALBERSDIRECTOR
Trustee or director
2$0
STUART A ARBUCKLEDIRECTOR
Trustee or director
2$0
MARTIN BABLERDIRECTOR
Trustee or director
2$0
MARIANNE DE BACKERDIRECTOR
Trustee or director
2$0
BRAD BAILEYDIRECTOR
Trustee or director
2$0
JACOB BECRAFTDIRECTOR
Trustee or director
2$0
SULAGNA BHATTACHARYADIRECTOR
Trustee or director
2$0
ROBERT BLUMDIRECTOR
Trustee or director
2$0
CARRIE L BOURDOWDIRECTOR (UNTIL DECEMBER 2024)
Trustee or director
2$0
CARINE BOUSTANYDIRECTOR
Trustee or director
2$0
DAVID BOYERDIRECTOR
Trustee or director
2$0
STEPHEN BRADYDIRECTOR
Trustee or director
2$0
CHRISTINE BRENNANDIRECTOR
Trustee or director
2$0
VICTOR BULTODIRECTOR
Trustee or director
2$0
JOHN BUTLERDIRECTOR
Trustee or director
2$0
GIACOMO CHIESIDIRECTOR
Trustee or director
2$0
JEFFREY L CLELANDDIRECTOR
Trustee or director
2$0
RON COHENDIRECTOR (UNTIL JUNE 2024)
Trustee or director
2$0
BRUCE C COZADDDIRECTOR
Trustee or director
2$0
MIKE DIALDIRECTOR
Trustee or director
2$0
ERIC M DUBEDIRECTOR
Trustee or director
2$0
MARC DUNOYERDIRECTOR
Trustee or director
2$0
MARK ENYEDYDIRECTOR (UNTIL MAY 2024)
Trustee or director
2$0
DAVID ESPOSITODIRECTOR
Trustee or director
2$0
BARRY P FLANNELLYDIRECTOR
Trustee or director
2$0
ALEXANDRIA FORBESDIRECTOR
Trustee or director
2$0
KAYE FOSTERDIRECTOR (UNTIL MAY 2024)
Trustee or director
2$0
CEDRIC FRANCOISDIRECTOR (UNTIL SEPTEMBER 2024)
Trustee or director
2$0
CARI GALLMANDIRECTOR
Trustee or director
2$0
KYLE GANODIRECTOR (UNTIL OCTOBER 2024)
Trustee or director
2$0
DEBORAH GLASSERDIRECTOR
Trustee or director
2$0
JOHN GLASSPOOLDIRECTOR
Trustee or director
2$0
JENNIFER GOODDIRECTOR
Trustee or director
2$0
KEVIN C GORMANDIRECTOR (UNTIL JUNE 2024)
Trustee or director
2$0
YVONNE GREENSTREETDIRECTOR
Trustee or director
2$0
SEBASTIAN GUTHDIRECTOR
Trustee or director
2$0
KARIS GUTTERDIRECTOR
Trustee or director
2$0
ALEXANDER HARDYDIRECTOR (UNTIL OCTOBER 2024)
Trustee or director
2$0
STEVEN HARRDIRECTOR
Trustee or director
2$0
RACHEL HAURWITZDIRECTOR
Trustee or director
2$0
KATE HAVILANDDIRECTOR
Trustee or director
2$0
DAVID HIRSCHIDIRECTOR
Trustee or director
2$0
JENNIFER HOLMGRENDIRECTOR
Trustee or director
2$0
CRISTIN HUBBARDDIRECTOR
Trustee or director
2$0
MIKE HUCKMANDIRECTOR
Trustee or director
2$0
ELIZABETH JEFFORDSDIRECTOR
Trustee or director
2$0
SABRINA JOHNSONDIRECTOR
Trustee or director
2$0
PATRIK JONSSONDIRECTOR
Trustee or director
2$0
DAVID KETTNERDIRECTOR
Trustee or director
2$0
NINA KJELLSONDIRECTOR
Trustee or director
2$0
SCOTT KOENIGDIRECTOR
Trustee or director
2$0
NEIL KUMARDIRECTOR
Trustee or director
2$0
JOSEPH J LAROSADIRECTOR
Trustee or director
2$0
CHRIS LEIBMANDIRECTOR
Trustee or director
2$0
JEREMY M LEVINDIRECTOR
Trustee or director
2$0
SANDY MACRAEDIRECTOR
Trustee or director
2$0
GAIL MADERISDIRECTOR (UNTIL SEPTEMBER 2024)
Trustee or director
2$0
ANTHONY MANCINIDIRECTOR (UNTIL OCTOBER 2024)
Trustee or director
2$0
MAYA MARTINEZ-DAVISDIRECTOR (UNTIL DECEMBER 2024)
Trustee or director
2$0
SHARON MATESDIRECTOR
Trustee or director
2$0
THOMAS P MATHERSDIRECTOR
Trustee or director
2$0
REENIE MCCARTHYDIRECTOR
Trustee or director
2$0
SHEILA ANN MIKHAILDIRECTOR
Trustee or director
2$0
FREDERICK MOOREDIRECTOR
Trustee or director
2$0
ROCCO MORELLIDIRECTOR (UNTIL MARCH 2024)
Trustee or director
2$0
MICHAEL M MORRISSEYDIRECTOR
Trustee or director
2$0
AMIR NASHATDIRECTOR (UNTIL JUNE 2024)
Trustee or director
2$0
SONIA NATHDIRECTOR
Trustee or director
2$0
ANDREW OBENSHAINDIRECTOR
Trustee or director
2$0
JANNIE OOSTHUIZENDIRECTOR
Trustee or director
2$0
CATHERINE OWENDIRECTOR (UNTIL JANUARY 2024)
Trustee or director
2$0
JULIA OWENSDIRECTOR
Trustee or director
2$0
JOHN V OYLERDIRECTOR (UNTIL JUNE 2024)
Trustee or director
2$0
CYNTHIA PERETTIEDIRECTOR
Trustee or director
2$0
RICHARD POPSDIRECTOR
Trustee or director
2$0
MARK PRUZANSKIDIRECTOR
Trustee or director
2$0
SOFIE QIAODIRECTOR (UNTIL MAY 2024)
Trustee or director
2$0
MIKE G RAABDIRECTOR
Trustee or director
2$0
MAGI RICHANIDIRECTOR
Trustee or director
2$0
MICHAEL J RUGGIERODIRECTOR
Trustee or director
2$0
JAMES SAPIRSTEINDIRECTOR
Trustee or director
2$0
CHRISTOPHE SCHILLINGDIRECTOR (UNTIL FEBRUARY 2024)
Trustee or director
2$0
MICHAEL SCHOENDIRECTOR
Trustee or director
2$0
HAROUT SEMERJIANDIRECTOR
Trustee or director
2$0
NANCY SIMONIANDIRECTOR (UNTIL FEBRUARY 2024)
Trustee or director
2$0
EDDIE J SULLIVANDIRECTOR
Trustee or director
2$0
IAN THOMPSONDIRECTOR (UNTIL OCTOBER 2024)
Trustee or director
2$0
NOLAN TOWNSENDDIRECTOR
Trustee or director
2$0
LINDA TROLINDERDIRECTOR (UNTIL JANUARY 2024)
Trustee or director
2$0
NEIL K WARMADIRECTOR
Trustee or director
2$0
FRANK WATANABEDIRECTOR
Trustee or director
2$0
SCOTT WHITEDIRECTOR
Trustee or director
2$0
LESLIE WILLIAMSDIRECTOR
Trustee or director
2$0
RICK E WINNINGHAMDIRECTOR
Trustee or director
2$0
SYLVIA WULFDIRECTOR
Trustee or director
2$0
TATSUYUKI YASUNODIRECTOR
Trustee or director
2$0
DAPHNE ZOHARDIRECTOR
Trustee or director
2$0
990 for the year ended December 31, 2023: 114 people
NameTitleHours / weekCompensationOther / benefits
MICHELLE MCMURRY-HEATHFORMER PRESIDENT AND CEO
Former
40$1,848,121$6,522
RACHEL K KINGINTERIM PRESIDENT AND CEO
Officer
40$1,267,480$64,672
RICHARD MASTERSCHIEF PUBLIC AFFAIRS & MARKETING OFFICER
Highest-paid employee
40$761,623$85,347
NICHOLAS SHIPLEYCHIEF ADVOCACY OFFICER
Highest-paid employee
40$758,821$80,397
STEPHEN JASKOCHIEF FINANCIAL OFFICER, EVP BUSINESS DEVELOPMENT
Officer
40$746,044$86,573
ELIZABETH ESHAMCHIEF SCIENCE OFFICER
Highest-paid employee
40$737,273$56,912
PETER MCHUGHCHIEF LEGAL OFFICER
Highest-paid employee
40$665,131$88,647
JOHN MURPHYCHIEF POLICY OFFICER
Highest-paid employee
40$550,953$87,604
GRACE E COLONEMERGING COMPANIES SECT. VICE CHAIR
Trustee or director, Officer
2$0$0
JOHN F CROWLEYHEALTH SECTION VICE CHAIR
Trustee or director, Officer
2$0$0
PAUL J HASTINGSIMMEDIATE PAST CHAIR
Trustee or director, Officer
2$0$0
ELIZABETH LEWISASSOCIATE VICE CHAIR & SECRETARY
Trustee or director, Officer
2$0$0
TED W LOVECHAIR
Trustee or director, Officer
2$0$0
ANNA RATHAGRICULTURE & ENVIRONMENT SECT CHAIR
Trustee or director, Officer
2$0$0
DUANE J SIMPSONAGRICULTURE & ENVIRONMENT VICE CHAIR
Trustee or director, Officer
2$0$0
ERIKA SMITHEMERGING COMPANIES SECTION CHAIR
Trustee or director, Officer
2$0$0
SYLVIA WULFAGRICULTURE & ENVIRONMENT SECT CHAIR
Trustee or director, Officer
2$0$0
BRADFORD A ZAKESTREASURER
Trustee or director, Officer
2$0$0
ANGELA CARISA AILLONIDIRECTOR
Trustee or director
2$0$0
STEVE ALBERSDIRECTOR
Trustee or director
2$0$0
STUART A ARBUCKLEDIRECTOR
Trustee or director
2$0$0
MARTIN BABLERDIRECTOR
Trustee or director
2$0$0
SULAGNA BHATTACHARYADIRECTOR
Trustee or director
2$0$0
JEAN-JACQUES BIENAIMEDIRECTOR (UNTIL DECEMBER 2023)
Trustee or director
2$0$0
FRITZ BITTENBENDERDIRECTOR
Trustee or director
2$0$0
ROBERT BLUMDIRECTOR
Trustee or director
2$0$0
CHRISTOPHER BOERNERDIRECTOR (UNTIL JUNE 2023)
Trustee or director
2$0$0
CARRIE L BOURDOWDIRECTOR
Trustee or director
2$0$0
CARINE BOUSTANYDIRECTOR
Trustee or director
2$0$0
STEPHEN BRADYDIRECTOR
Trustee or director
2$0$0
VICTOR BULTODIRECTOR
Trustee or director
2$0$0
EMMANUEL CAEYMAEXDIRECTOR (UNTIL DECEMBER 2023)
Trustee or director
2$0$0
PABLO J CAGNONIDIRECTOR (UNTIL OCTOBER 2023)
Trustee or director
2$0$0
KAY CHANDLERDIRECTOR (UNTIL DECEMBER 2023)
Trustee or director
2$0$0
IVAN CHEUNGDIRECTOR (UNTIL SEPTEMBER 2023)
Trustee or director
2$0$0
GIACOMO CHIESIDIRECTOR
Trustee or director
2$0$0
JEFFREY L CLELANDDIRECTOR
Trustee or director
2$0$0
RON COHENDIRECTOR
Trustee or director
2$0$0
BRUCE C COZADDDIRECTOR
Trustee or director
2$0$0
ROGER CRYSTALDIRECTOR (UNTIL JUNE 2023)
Trustee or director
2$0$0
DOUGLAS DOERFLERDIRECTOR (UNTIL DECEMBER 2023)
Trustee or director
2$0$0
ERIC M DUBEDIRECTOR
Trustee or director
2$0$0
MARC DUNOYERDIRECTOR
Trustee or director
2$0$0
MARK ENYEDYDIRECTOR
Trustee or director
2$0$0
BARRY P FLANNELLYDIRECTOR
Trustee or director
2$0$0
ALEXANDRIA FORBESDIRECTOR
Trustee or director
2$0$0
KAYE FOSTERDIRECTOR
Trustee or director
2$0$0
CEDRIC FRANCOISDIRECTOR
Trustee or director
2$0$0
DEBORAH GLASSERDIRECTOR
Trustee or director
2$0$0
JOHN GLASSPOOLDIRECTOR
Trustee or director
2$0$0
JENNIFER GOODDIRECTOR
Trustee or director
2$0$0
KEVIN C GORMANDIRECTOR
Trustee or director
2$0$0
YVONNE GREENSTREETDIRECTOR
Trustee or director
2$0$0
SEBASTIAN GUTHDIRECTOR
Trustee or director
2$0$0
KARIS GUTTERDIRECTOR
Trustee or director
2$0$0
STEVEN HARRDIRECTOR
Trustee or director
2$0$0
RACHEL HAURWITZDIRECTOR
Trustee or director
2$0$0
JENNIFER HOLMGRENDIRECTOR
Trustee or director
2$0$0
MIKE HUCKMANDIRECTOR
Trustee or director
2$0$0
ELIZABETH JEFFORDSDIRECTOR
Trustee or director
2$0$0
PATRIK JONSSONDIRECTOR
Trustee or director
2$0$0
ALEX KARNALDIRECTOR (UNTIL OCTOBER 2023)
Trustee or director
2$0$0
DAVID KETTNERDIRECTOR
Trustee or director
2$0$0
SCOTT KOENIGDIRECTOR
Trustee or director
2$0$0
SAMARTH KULKARNIDIRECTOR (UNTIL MAY 2023)
Trustee or director
2$0$0
JOSEPH J LAROSADIRECTOR
Trustee or director
2$0$0
CHRIS LEIBMANDIRECTOR
Trustee or director
2$0$0
JEREMY M LEVINDIRECTOR
Trustee or director
2$0$0
SANDY MACRAEDIRECTOR
Trustee or director
2$0$0
GAIL MADERISDIRECTOR
Trustee or director
2$0$0
AAMIR MALIKDIRECTOR (UNTIL DECEMBER 2023)
Trustee or director
2$0$0
ANTHONY MANCINIDIRECTOR
Trustee or director
2$0$0
MAYA MARTINEZ-DAVISDIRECTOR
Trustee or director
2$0$0
SHARON MATESDIRECTOR
Trustee or director
2$0$0
THOMAS P MATHERSDIRECTOR
Trustee or director
2$0$0
REENIE MCCARTHYDIRECTOR
Trustee or director
2$0$0
SHEILA ANN MIKHAILDIRECTOR
Trustee or director
2$0$0
ROCCO MORELLIDIRECTOR
Trustee or director
2$0$0
MICHAEL M MORRISSEYDIRECTOR
Trustee or director
2$0$0
MICHAEL NARACHIDIRECTOR (UNTIL FEBRUARY 2023)
Trustee or director
2$0$0
AMIR NASHATDIRECTOR
Trustee or director
2$0$0
WILLIAM J NEWELLDIRECTOR
Trustee or director
2$0$0
ANDREW OBENSHAINDIRECTOR
Trustee or director
2$0$0
JANNIE OOSTHUIZENDIRECTOR
Trustee or director
2$0$0
CATHERINE OWENDIRECTOR
Trustee or director
2$0$0
JULIA OWENSDIRECTOR
Trustee or director
2$0$0
JOHN V OYLERDIRECTOR
Trustee or director
2$0$0
CINDY PERETTIEDIRECTOR
Trustee or director
2$0$0
ADELENE Q PERKINSDIRECTOR (UNTIL OCTOBER 2023)
Trustee or director
2$0$0
RICHARD POPSDIRECTOR
Trustee or director
2$0$0
MARK PRUZANSKIDIRECTOR
Trustee or director
2$0$0
SOFIE QIAODIRECTOR
Trustee or director
2$0$0
MIKE G RAABDIRECTOR
Trustee or director
2$0$0
ELENA RICEDIRECTOR (UNTIL DECEMBER 2023)
Trustee or director
2$0$0
MICHAEL J RUGGIERODIRECTOR
Trustee or director
2$0$0
JAMES SAPIRSTEINDIRECTOR
Trustee or director
2$0$0
CHRISTOPHE SCHILLINGDIRECTOR
Trustee or director
2$0$0
HAROUT SEMERJIANDIRECTOR
Trustee or director
2$0$0
CHRISTI SHAWDIRECTOR (UNTIL MARCH 2023)
Trustee or director
2$0$0
JEFFREY SHERMANDIRECTOR (UNTIL OCTOBER 2023)
Trustee or director
2$0$0
BILL SIBOLDDIRECTOR (UNTIL SEPTEMBER 2023)
Trustee or director
2$0$0
NANCY SIMONIANDIRECTOR
Trustee or director
2$0$0
EDDIE J SULLIVANDIRECTOR
Trustee or director
2$0$0
IAN THOMPSONDIRECTOR
Trustee or director
2$0$0
NOLAN TOWNSENDDIRECTOR
Trustee or director
2$0$0
LINDA TROLINDERDIRECTOR
Trustee or director
2$0$0
NEIL K WARMADIRECTOR
Trustee or director
2$0$0
SUE WASHERDIRECTOR (UNTIL MARCH 2023)
Trustee or director
2$0$0
FRANK WATANABEDIRECTOR
Trustee or director
2$0$0
SCOTT WHITEDIRECTOR
Trustee or director
2$0$0
RICK E WINNINGHAMDIRECTOR
Trustee or director
2$0$0
ROGER WYSEDIRECTOR (UNTIL DECEMBER 2023)
Trustee or director
2$0$0
TATSUYUKI YASUNODIRECTOR
Trustee or director
2$0$0
DAPHNE ZOHARDIRECTOR
Trustee or director
2$0$0

Address and contacts

Address (IRS master file)
1201 NEW YORK AVE NW STE 1300, WASHINGTON, DC 20005-4853
Principal officer (990 for 2024)
JOHN CROWLEY, 1201 NEW YORK AVE NW NO 1300, WASHINGTON, DC 20005
Signed the 990
STEPHEN JASKO, CHIEF BUSN & FINANCIAL OFFICER
Phone
(202) 962-9200
Return prepared by
CLIFTONLARSONALLEN LLP

Mission

THE BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) REPRESENTS APPROXIMATELY 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES.

990 for the year ended December 31, 2024

Program accomplishments

  • ADVOCACY: BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE THREE SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS FOR THE YEAR ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT PROACTIVELY ADVANCING THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION ADVOCACY ACCOMPLISHMENTS: - PROMOTED HEALTHCARE POLICIES THAT RECOGNIZE BOTH THE PROMISE AND VALUE OF INNOVATION.- ADVOCATED FOR A SAFE AND PREDICTABLE REGULATORY ENVIRONMENT FOR VALUE-BASED PAYMENT ARRANGEMENTS FOR DRUGS AND BIOLOGICS.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES AND PROMOTED THE NEED FOR GREATER NONDISCRIMINATION ENFORCEMENT AGAINST INSURANCE BENEFIT DESIGNS.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY, PROMOTE BIOMEDICAL INNOVATION, AND ADVANCE THE SCIENCE-BASED REVIEW AND APPROVAL OF BIOSIMILARS AND INTERCHANGEABLE BIOLOGICAL PRODUCTS.- PROMOTED THE VALUE OF U.S. GOVERNMENT INVESTMENTS IN PROGRAMS THAT IMPROVE ACCESS TO IMMUNIZATIONS AND FOSTER VACCINE INNOVATION, STRENGTHENED OUR ABILITY TO RESPOND TO BIOTERROR THREATS OR EMERGING INFECTIOUS DISEASES, AND ENCOURAGED DEVELOPMENT OF NEW PRODUCTS TO FIGHT ANTIMICROBIAL RESISTANCE (AMR).- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION AND GLOBAL PUBLIC HEALTH PREPAREDNESS.- ADVOCATED FOR THE MODERNIZATION OF THE CLINICAL DEVELOPMENT PARADIGM.THE EMERGING COMPANIES SECTION ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR FISCAL POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES AND INVESTMENT IN GROUNDBREAKING R&D; ENHANCED THE VOICE OF PRE-REVENUE, R&D-INTENSIVE BUSINESSES- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.THE AGRICULTURE & ENVIRONMENT SECTION ADVOCACY ACCOMPLISHMENTS:BIO'S AGRICULTURE & ENVIRONMENT (OR AG & ENVIRONMENT) SECTION FOCUSES ON ISSUES RELATED TO THE ORGANIZATION'S PRIOR FOOD & AGRICULTURE AND INDUSTRIAL & ENVIRONMENT SECTIONS. THESE INCLUDE:- ADVOCATING ON INITIATIVES THAT STRENGTHEN THE BIOECONOMY; AND- MEETING SHARED GOALS RELATED TO SOCIETAL CHALLENGES SUCH AS FOOD SECURITY, NATIONAL SECURITY AND CLIMATE CHANGE.THE AG & ENVIRONMENT SECTION ADVOCATES AND COORDINATES DIRECTLY WITH GOVERNMENT AND INDUSTRY STAKEHOLDERS TO INCREASE THE UNDERSTANDING AND ACCEPTANCE OF BIOTECH INNOVATION, WHILE ALSO IMPROVING THE REGULATORY AND APPROVAL PROCESSES. THIS SECTION PROMOTES APPROPRIATE INITIATIVES THAT SUPPORT INNOVATION, MARKET ACCESS, AND MARKET ACCEPTANCE.
  • SERVICES: BIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING ADVOCACY ACCOMPLISHMENTS LISTED BELOW:- SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT PROACTIVELY ADVANCING THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- BROUGHT TOGETHER INDUSTRY STAKEHOLDERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES.THE BIO INTERNATIONAL CONVENTION ATTRACTS THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 69 COUNTRIES AND 50 U.S. STATES, AS WELL AS THE DISTRICT OF COLUMBIA AND PUERTO RICO AND OFFERS PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES.THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. THE BIO BUSINESS FORUM AT THE CONVENTION HOSTS TENS OF THOUSANDS OF PARTNERING MEETINGS AMONG A FEW THOUSAND COMPANIES, ALONG WITH A COUPLE HUNDRED COMPANY PRESENTATIONS. THE CONVENTION HOSTS HUNDREDS OF SPEAKERS, AND OVER A THOUSAND EXHIBITIONS WITH INTERNATIONAL, REGIONAL AND STATE PAVILIONS (AND A NUMBER OF PRODUCT FOCUS ZONES).BEYOND THE CONVENTION, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS.

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
52-1224577
Tax-exempt status
501(c)(6): Business league or chamber of commerce
Exempt since
1982
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$170,089,094
Income (IRS master file)
$214,116,938

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$117,748,708$100,010,786$170,089,094IRS
990December 2023$113,768,509$91,630,164$156,639,347XML
990December 2022$103,185,175$86,344,110$124,412,600IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 52-1224577).

Questions about BIOTECHNOLOGY INNOVATION ORGANIZATION

What is the EIN of BIOTECHNOLOGY INNOVATION ORGANIZATION?
The employer identification number (EIN) of BIOTECHNOLOGY INNOVATION ORGANIZATION is 52-1224577.
Is BIOTECHNOLOGY INNOVATION ORGANIZATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(6) since 1982.
Which annual return does BIOTECHNOLOGY INNOVATION ORGANIZATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of BIOTECHNOLOGY INNOVATION ORGANIZATION due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did BIOTECHNOLOGY INNOVATION ORGANIZATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of BIOTECHNOLOGY INNOVATION ORGANIZATION?
The 990 for the year ended December 31, 2024 names JOHN CROWLEY.
Who are the officers and directors of BIOTECHNOLOGY INNOVATION ORGANIZATION?
The 990 for the year ended December 31, 2024 lists 118 people; 9 received compensation from the organization, the highest $2,747,033 (JOHN F CROWLEY, PRESIDENT AND CEO).
How much revenue does BIOTECHNOLOGY INNOVATION ORGANIZATION have?
On its 990 for the year ended December 31, 2024 it reported revenue of $117,748,708, expenses of $100,010,786 and total assets of $170,089,094 at year end.

Other nonprofits in WASHINGTON

All nonprofits in WASHINGTON · District of Columbia